Labiotech.eu

Chikungunya vaccine clinical trial Valneva

News and Trends 19 Aug 2021

Chikungunya Vaccine First to Succeed in Phase III Trial

In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya may become preventable with a new vaccine candidate from French biotech Valneva that just passed phase III trials. The results of the phase III trial revealed that a single dose of the live attenuated vaccine developed by Valneva induced the […]

August 19, 2021 - 3 minutesmins - By Victor Kotsev

Expert Advice 18 Aug 2021

How to Pitch Your Biotech Startup to a Life Sciences Investor

You’ve got the idea. You’ve got the science. You’ve got the team. Now all you need is the money, but that can be a tricky step for a new biotech entrepreneur. In any field, getting in front of the right investors is a challenge of its own. Once you’re pitching, experienced investors and entrepreneurs say […]

August 18, 2021 - 9 minutesmins - By Mark Zipkin

News and Trends 17 Aug 2021

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are interested in messenger RNA technologies beyond Covid-19. Based in Boston, US, Translate Bio develops mRNA therapies for a range of conditions, including respiratory, liver, and infectious diseases. The company’s €2.7B ($3.2B) buyout, announced by Sanofi earlier this month, seems a […]

August 17, 2021 - 5 minutesmins - By Mark Zipkin

In Depth 16 Aug 2021

Plants Allow Astronauts to Make Medicines in Space

As humans venture into deep space travel, plants might become essential to keep astronauts healthy on years-long trips to Mars. Astronauts have been taking medicines with them on space missions since the beginning of space travel. The crew on the Apollo 11 mission that landed on the Moon carried antibiotics, painkillers, nasal sprays, and sleeping […]

August 16, 2021 - 7 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Aug 2021

European Biotechs Fire up Deals to Develop Parkinson’s Treatments

Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or license treatments for Parkinson’s disease. For some experts, this increasing interest in the brain disease with the fastest growing prevalence is long overdue. In July, Swiss company AC Immune bought assets and intellectual property for investigational Parkinson’s vaccines valued at […]

August 12, 2021 - 4 minutesmins - By Anita Chakraverty

Opinion 11 Aug 2021

Investors Turn to Biotechnology for a Sustainable Future

The next industrial revolution is going to be a bio-revolution. It has to be, given that the byproducts of the original industrial revolution created the major pollution problems we now have to solve. But alongside the fixes, we also need to feed and heal a growing population efficiently and sustainably. The bio-revolution is already well […]

August 11, 2021 - 6 minutesmins - By External Contributor

biotech funding cultured meat agriculture

News and Trends 10 Aug 2021

The Top European Biotech Funding Rounds in July

Nordic biotechs yielded some of Europe’s biggest biotech funding rounds in July, as did developers of cultured meat and other protein alternatives. July saw a continuing buzz of biotech fundraising activity in Europe. In the venture capital arena, the investors Sofinnova and Panakès Partners closed new funds to target life sciences companies, including those in […]

August 10, 2021 - 5 minutesmins - By Jonathan Smith

News and Trends 6 Aug 2021

Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer

The UK firm Artios Pharma raised a huge Series C round last week in one of many efforts to develop cancer drugs that target the DNA repair systems of our cells. Artios Pharma bagged €129M (£110M) last week in a venture capital round led by the US-based firms Omega Funds and TCG X. The proceeds […]

August 6, 2021 - 4 minutesmins - By Anita Chakraverty

biotech startups alternative funding e1578394660261

In Depth 4 Aug 2021

Ditch the VC: Alternative Funding Options for Biotech Startups

Getting money for a biotech startup can be a daunting task. Venture capital is not the only — and not always the best — option to fund a life sciences company. “A lot of entrepreneurs, particularly young first-time entrepreneurs, think venture capital is the only way to build up a company,” said Andreas Schmidt. Ten […]

August 4, 2021 - 9 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 Aug 2021

Oral and Nasal Covid-19 Vaccines Hit Clinical Testing

Oramed’s jab-free oral Covid-19 vaccine is one of many in the form of pills, powders, or sprays that may hit the market in the next few years, which could dramatically expand vaccine rollout and uptake. An Israeli team is preparing to start trials of what could be the first Covid-19 vaccine pill. The vaccine consists […]

August 3, 2021 - 5 minutesmins - By Victor Kotsev

Expert Advice 2 Aug 2021

The Path to Becoming a Chief Medical Officer in the Biotech Industry

Life science researchers with an entrepreneurship inclination are often attracted to leadership positions with a focus on medical science. Daniel Chung shares his journey to becoming the Chief Medical Officer of the biotech startup SparingVision. Within a biotech company, a Chief Medical Officer (CMO) typically oversees and sets the company’s strategy and direction regarding the […]

August 2, 2021 - 6 minutesmins - By Victor Kotsev

News and Trends 30 Jul 2021

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by a group of philanthropic funds and investors, in what experts predict may become an increasingly popular trend. The British biotech Mologic will entirely reinvest any profits into widening global access to affordable medical technology after being acquired in a deal […]

July 30, 2021 - 4 minutesmins - By Anita Chakraverty

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Chikungunya Vaccine First to Succeed in Phase III Trial

How to Pitch Your Biotech Startup to a Life Sciences Investor

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Plants Allow Astronauts to Make Medicines in Space

European Biotechs Fire up Deals to Develop Parkinson’s Treatments

Investors Turn to Biotechnology for a Sustainable Future

The Top European Biotech Funding Rounds in July

Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer

Ditch the VC: Alternative Funding Options for Biotech Startups

Oral and Nasal Covid-19 Vaccines Hit Clinical Testing

The Path to Becoming a Chief Medical Officer in the Biotech Industry

British Diagnostics Biotech Becomes Social Enterprise After Acquisition

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!